Subsidiaries

  ​ ​ ​

Date of 
incorporation

  ​ ​ ​

Place of 
incorporation

  ​ ​ ​

Ownership

  ​ ​ ​

Principal 
activities

Belite Bio Holdings Corp. (“Belite Holding”)

​

June 10, 2016

​

The United States of America

​

100% owned by Belite

​

Commercial preparation, marketing, distribution, and sales of pharmaceutical products

​

Belite Bio, LLC (“Belite USA”)

​

June 10, 2016

​

The United States of America

​

100% owned by Belite Holding

​

Research and development

​

RBP4 Pty Ltd (“RBP4”)

​

August 13, 2018

​

Australia

​

100% owned by Belite Holding

​

Clinical trial activities

​

Belite Bio (HK) Limited (“Belite HK”)

​

June 10, 2021

​

Hong Kong

​

100% owned by Belite

​

Clinical trial activities

​

Belite Bio (Shanghai) Limited (“Belite Shanghai”)

​

August 12, 2021

​

China

​

100% owned by Belite HK

​

Clinical trial activities

​

Belite Bio (Taiwan) Inc (“Belite Taiwan”)

​

December 18, 2024

​

Taiwan

​

100% owned by Belite HK

​

Supporting clinical trial activities, research and development and back-office service

​

Belite Bio (Swiss) AG (“Belite Swiss”)

​

September 1, 2025

​

Switzerland

​

100% owned by Belite HK

​

Conducting research and development, marketing, distribution, and sales of pharmaceutical products

​

Belite Bio Japan Inc (“Belite Japan”)

​

November 14, 2025

​

Japan

​

100% owned by Belite Swiss

​

Marketing, distribution, and sales of pharmaceutical products

​